Used as a key intermediate in the synthesis of tyrosine kinase inhibitors, particularly in pharmaceuticals targeting cancer treatment. It plays a role in the development of selective kinase inhibitors due to its ability to bind effectively with enzyme active sites. Its structure supports the design of drugs aimed at blocking abnormal signaling pathways in tumor cells. Commonly utilized in research and development of targeted therapies for solid tumors and hematological malignancies.